FDA DEVICE FACTS
VI°Port™ Liver Preservation System
Traferox Technologies, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The VI°Port™ Liver Preservation System is intended to be used for the static hypothermic preservation of livers during transportation and eventual transplantation into a recipient, using cold storage solutions indicated for use with the livers. The intended organ storage time for the VI°Port™ Liver Preservation System is up to 15 hours. When clinically accepted static hypothermic preservation times are exceeded, the livers should be evaluated by the transplant surgeon to determine transplantability in accordance with accepted clinical guidelines and in the best medical interest of the intended recipient.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。